Wnt5a Signaling in Normal and Cancer Stem Cells by Yan Zhou, Thomas J. Kipps, Suping Zhang

Get full text

A + AVD for Treatment of Hodgkin Lymphoma Variant of Richter’s Transformation by Benjamin Heyman, Michael Choi, Thomas J. Kipps

Get full text

Corrigendum to “Wnt5a Signaling in Normal and Cancer Stem Cells” by Yan Zhou, Thomas J. Kipps, Suping Zhang

Get full text

Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis. by Morgan O'Hayre, Catherina L Salanga, Thomas J Kipps, Davorka Messmer, Pieter C Dorrestein, Tracy M Handel

Get full text

Variant Transcript of ROR1 ENST00000545203 Does Not Encode ROR1 Protein by Jie Xian, Navyaa Sinha, Christina Girgis, Christopher S. Oh, Matthew R. Cring, George F. Widhopf, Thomas J. Kipps

Get full text

B-cell Receptor Signaling Induced Metabolic Alterations in Chronic Lymphocytic Leukemia Can Be Partially Bypassed by TP53 Abnormalities by Katarina Kluckova, Andrew J. Clear, Annalisa D’Avola, Laura Z. Rassenti, Thomas J. Kipps, John G. Gribben, John C. Riches

Get full text

ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth. by Suping Zhang, Liguang Chen, Bing Cui, Han-Yu Chuang, Jianqiang Yu, Jessica Wang-Rodriguez, Li Tang, George Chen, Grzegorz W Basak, Thomas J Kipps

Get full text

Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma by Steven Coutre, Alessandra Tedeschi, Tadeusz Robak, Paul M. Barr, Carolyn Owen, Osnat Bairey, Jan Burger, Cathy Zhou, Lori Styles, Danelle F. James, Thomas J. Kipps

Get full text

IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope. by Xuchu Que, George F Widhopf, Shahzada Amir, Karsten Hartvigsen, Lotte F Hansen, Douglas Woelkers, Sotirios Tsimikas, Christoph J Binder, Thomas J Kipps, Joseph L Witztum

Get full text

Targeting ROR2 homooligomerization disrupts ROR2-dependent signaling and suppresses stem-like cell properties of human breast adenocarcinoma by Feng Leng, Jiajia Huang, Liufeng Wu, Jianchao Zhang, Xinxin Lin, Ruhuan Deng, Jinhang Zhu, Zhen Li, Zhenghao Li, Yimeng Wang, Han Zhang, Desheng Lu, Thomas J. Kipps, Suping Zhang

Get full text

Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels by Juliana Velez Lujan, Paula A. Lengerke-Diaz, Chaja Jacobs, Eider F. Moreno-Cortes, Cesar A. Ramirez-Segura, Michael Y. Choi, Colin McCarthy, Alaina Heinen, Thomas J. Kipps, Januario E. Castro

Get full text

Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B by Manoj K. Kashyap, Deepak Kumar, Reymundo Villa, James J. La Clair, Chris Benner, Roman Sasik, Harrison Jones, Emanuela M. Ghia, Laura Z. Rassenti, Thomas J. Kipps, Michael D. Burkart, Januario E. Castro

Get full text

cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies by Christina Bligaard Pedersen, Søren Helweg Dam, Mike Bogetofte Barnkob, Michael D. Leipold, Noelia Purroy, Laura Z. Rassenti, Thomas J. Kipps, Jennifer Nguyen, James Arthur Lederer, Satyen Harish Gohil, Catherine J. Wu, Lars Rønn Olsen

Get full text

Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia by Kerry A. Rogers, Philip A. Thompson, John N. Allan, Morton Coleman, Jeff P. Sharman, Bruce D. Cheson, Daniel Jones, Raquel Izumi, Melanie M. Frigault, Cheng Quah, Rakesh K. Raman, Priti Patel, Min Hui Wang, Thomas J. Kipps

Get full text

Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after... by Januario E. Castro, Paula A. Lengerke-Diaz, Juliana Velez Lujan, Michael Y. Choi, Eider F. Moreno-Cortes, Jose V. Forero, Juan Esteban Garcia-Robledo, Chaja Jacobs, Colin McCarthy, Alaina Heinen, Carlos I. Amaya-Chanaga, Thomas J. Kipps

Get full text

Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations. by Drew C Deniger, Jianqiang Yu, M Helen Huls, Matthew J Figliola, Tiejuan Mi, Sourindra N Maiti, George F Widhopf, Lenka V Hurton, Radhika Thokala, Harjeet Singh, Simon Olivares, Richard E Champlin, William G Wierda, Thomas J Kipps, Laurence J N Cooper

Get full text

A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer by Rebecca A. Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B. Schwab, Emily I. Pittman, Minya Pu, Elizabeth Weihe, Emanuela M. Ghia, Laura Z. Rassenti, Alfredo Molinolo, Betty Cabrera, James B. Breitmeyer, George F. Widhopf, Karen Messer, Catriona Jamieson, Thomas J. Kipps, Barbara A. Parker

Get full text

A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma by Alessandra Tedeschi, Richard Greil, Fatih Demirkan, Tadeusz Robak, Carol Moreno, Paul M. Barr, Bertrand Anz, David Simpson, Gianluca Gaidano, Osnat Bairey, Don Stevens, Devinder Gill, Ian W. Flinn, Thomas J. Kipps, Jan A. Burger, Jennifer Lin, Thomas Webb, Viktor Fedorov, Lori Styles, John G. Gribben

Get full text

A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma by Jennifer R. Brown, Bradley Messmer, Lillian Werner, Matthew S. Davids, Evgeny Mikler, Jeffrey G. Supko, David C. Fisher, Ann S. LaCasce, Philippe Armand, Eric Jacobsen, Virginia Dalton, Bethany Tesar, Stacey M. Fernandes, Sean McDonough, Jerome Ritz, Laura Rassenti, Thomas J. Kipps, Donna Neuberg, Arnold S. Freedman

Get full text

Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry by Veronica D. Gonzalez, Nikolay Samusik, Tiffany J. Chen, Erica S. Savig, Nima Aghaeepour, David A. Quigley, Ying-Wen Huang, Valeria Giangarrà, Alexander D. Borowsky, Neil E. Hubbard, Shih-Yu Chen, Guojun Han, Alan Ashworth, Thomas J. Kipps, Jonathan S. Berek, Garry P. Nolan, Wendy J. Fantl

Get full text